Establishes a first-of-its-kind view of the genome encompassing
both germline and somatic variants with inclusion of CKB cancer
insights
ANN
ARBOR, Mich., May 8, 2024
/PRNewswire-PRWeb/ -- Genomenon, a genomic intelligence company
today announced its acquisition of the Clinical Knowledgebase (CKB)
from The Jackson Laboratory (JAX). CKB is the leading curated
variant database used for interpreting complex cancer genomic
profiles by some of the world's premier oncology labs. This
strategic acquisition enables Genomenon to provide an unprecedented
understanding of the genome, with insights now covering both
germline and somatic variants, furthering its lead in the race to
curate the genome. Financial terms of the acquisition were not
disclosed.
"The acquisition of CKB is a significant
step in Genomenon's mission to curate the entire human genome,"
shared Mike Klein, CEO of
Genomenon.
Genomenon combines its genomic expertise with its AI-driven
technology to deliver actionable insights to leading clinical
diagnostic laboratories and precision therapeutic companies. CKB
provides up-to-date data on somatic variants to oncology
professionals, supporting researchers and clinicians with their
interpretation of complex cancer genomic profiles. Together, their
comprehensive offerings will serve the industry's needs and
encompass all types of genomic variants.
"The acquisition of CKB is a significant step in Genomenon's
mission to curate the entire human genome," shared Mike Klein, CEO of Genomenon. "By integrating
the CKB team's expertise in cancer genomics with our curation of
the germline clinical exome, we are poised to offer unparalleled
genomic intelligence solutions to the scientific and clinical
community." He added, "CKB is esteemed by researchers and
clinicians for delivering rich discoveries into somatic genomics,
which is crucial for advancing cancer diagnosis and treatment. We
are honored to have them as part of the Genomenon family as we work
collectively to make genomic information actionable and ultimately,
save lives."
"Our team of dedicated scientists and software developers has
shaped CKB into the most comprehensive cancer genomic database
available over the last eight years," said Mitch Kennedy, Executive Vice President of JAX
and President of JAX Mice, Clinical and Research Services (JMCRS).
"We've built a vital resource that empowers researchers and
clinicians to make a meaningful impact in the fight against cancer
and we're thrilled that Genomenon has acquired CKB, recognizing its
immense value and potential for future growth. We're confident they
will continue to nurture and expand CKB, advancing precision
medicine and improving patient outcomes."
In June 2023, Genomenon announced
the acquisition of Boston Genetics as part of its mission to curate
the human genome. In October 2023,
the company reached a major milestone in its mission with the
curation of the clinical exome at the gene level. The acquisition
of CKB is effective immediately.
About Genomenon
Genomenon is a leading genomic intelligence company dedicated to
improving the quality of patients' lives by uncovering the genomic
drivers of genetic disease and cancer. Blending the power of AI
with genomic expertise, Genomenon simplifies complex genetic data
into actionable insights for patient diagnosis and precision
medicine development. The company's solutions include software,
data, and services.
About The Jackson Laboratory
The Jackson Laboratory is an independent, nonprofit biomedical
research institution with a National Cancer Institute-designated
Cancer Center and more than 3,000 employees in
locations across the United
States, Japan and
China. Its mission is to discover
precise genomic solutions for disease and to empower the global
biomedical community in the shared quest to
improve human health. For more information, please visit
http://www.jax.org.
Media Contact:
Christine Quern
cq@christinequern.com
Media Contact
Christine Quern, Genomenon, (617) 650-8497,
cq@christinequern.com, https://www.genomenon.com
Twitter
View original content to download
multimedia:https://www.prweb.com/releases/genomenon-acquires-the-jackson-laboratorys-clinical-knowledgebase-ckb-to-fuel-its-mission-to-curate-the-human-genome-302138731.html
SOURCE Genomenon